Preferred Label : goserelin;

MeSH definition : A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.;

MeSH hyponym : goserelin acetate; ICI-118630; zoladex; ICI 118630; ICI118630; Acetate, Goserelin;

MeSH CAS label : luteinizing hormone-releasing factor (pig), 6-(O-(1,1-dimethylethyl)-D-serine)-10-deglycinamide-, 2-(aminocarbonyl)hydrazide;

MeSH Related Number : 65807-02-5 (Goserelin);

Registry Number MeSH : 65807-02-5;

Wikipedia link : https://en.wikipedia.org/wiki/Goserelin;

Is substance : O;

UNII : 0F65R8P09N;

InChIKey : BLCLNMBMMGCOAS-URPVMXJPSA-N;

Details


Main resources

You can consult :

A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.

http://www.has-sante.fr/portail/jcms/c_2672233/fr/zoladex
2016
false
France
French
goserelin
drug implants
injections, subcutaneous
antineoplastic agents, hormonal
insurance, health, reimbursement
prostatic neoplasms
neoplasm metastasis
breast neoplasms
neoplasms, hormone-dependent
chemotherapy, adjuvant
goserelin
treatment outcome
evaluation of the transparency committee

---
http://www.pharmactuel.com/index.php/pharmactuel/article/view/1075
2016
false
false
false
false
Canada
French
critical appraisal or critical reading
antineoplastic combined chemotherapy protocols
ovary
infertility, female
menopause, premature
gonadotropin-releasing hormone
clinical trials, phase iii as topic
breast neoplasms
chemotherapy, adjuvant
goserelin

---
Nous contacter.
26/04/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.